Cancer and Age: General Considerations

Clinics in Geriatric Medicine

Volumn 28, Issue 1, 2012, Pages 1-18

  Hoffe, Sarah ^a   Balducci, Lodovico ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Aging; Cancer; Chemotherapy; Management; Prevention; Treatment

Indexed keywords

ABIRATERONE; ANASTROZOLE; ANDROGEN; ANTIANDROGEN; AROMATASE INHIBITOR; CANCER VACCINE; CARCINOGEN; CYTOKINE; CYTOTOXIC AGENT; DIETHYLSTILBESTROL; DUTASTERIDE; ESTROGEN; EXEMESTANE; FINASTERIDE; FULVESTRANT; GESTAGEN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADORELIN DERIVATIVE; KETOCONAZOLE; LETROZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTATE SPECIFIC ANTIGEN; RADIOISOTOPE; RALOXIFENE; RETINOIC ACID; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; TOREMIFENE; UNINDEXED DRUG;

AGING; ARTHRALGIA; BIOLOGICAL THERAPY; BREAST CANCER; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SCREENING; CANCER SURGERY; CARCINOGENESIS; CARDIOVASCULAR DISEASE; CHEMOPROPHYLAXIS; CLINICAL FEATURE; COLORECTAL CANCER; DEEP VEIN THROMBOSIS; EARLY DIAGNOSIS; ENDOMETRIUM CANCER; ENDOSCOPIC THERAPY; GERIATRIC ASSESSMENT; GYNECOMASTIA; HOT FLUSH; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LARGE INTESTINE CANCER; LIBIDO DISORDER; LIVER TUMOR; LUNG CANCER; MEDICAL DECISION MAKING; MENOPAUSAL SYNDROME; MOLECULARLY TARGETED THERAPY; MULTIPLE CANCER; NEOPLASM; OSTEOPOROSIS; PROSTATE CANCER; RADIOFREQUENCY ABLATION; RESPIRATORY TRACT CANCER; REVIEW; TUMOR ABLATION;

AGED; AGING; ANTICARCINOGENIC AGENTS; DECISION MAKING; EARLY DETECTION OF CANCER; FEMALE; FRAIL ELDERLY; FRANCE; GERIATRIC ASSESSMENT; HUMANS; LIFE EXPECTANCY; MALE; NEOPLASMS; PATIENT CARE PLANNING; PROGNOSIS; RISK FACTORS; SEX DISTRIBUTION;

EID: 84856788425     PISSN: 07490690     EISSN: 18798853     Source Type: Journal    
DOI: 10.1016/j.cger.2011.09.001     Document Type: Review

References (82)

1. Smith B.D., Smith G.L., Hurria A., et al. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol 2009, 27:2758-2765.
2. Yancik R., Ries L.A. Cancer in the older person. An international issue in an aging world. Semin Oncol 2004, 31:128-136.
3. Balducci L., Ershler W.B. Cancer and aging: a nexus at several levels. Nat Rev Cancer 2005, 5:655-662.
4. Vineis P., Schatzkin A., Potter J.D. Models of carcinogenesis: an overview. Carcinogenesis 2010, 31:1703-1709.
5. Edwards B.K., Brown M.L., Wingo P.A., et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 2005, 97:1407-1427.
6. Crispo A., Brennan P., Jöckel K.H., et al. The cumulative risk of lung cancer among current, ex- and never-smokers in European men. Br J Cancer 2004, 91:1280-1286.
7. Freedman D.A., Navidi W.C. Ex-smokers and the multistage model for lung cancer. Epidemiology 1990, 1:21-29.
8. Gravina S., Vijg J. epigenetic factors in aging and longevity. Pflugers Arch 2010, 459:247-258.
9. Anisimov V.N., Sikora E., Pawelec G. Relationship between cancer and aging: a multilevel approach. Biogerontology 2009, 10:323-338.
10. Brenner H., Chang-Claude J., Seiler C.M., et al. Case-control study supports extension of surveillance interval after colonoscopic polypectomy to at least 5 yr. Am J Gastroenterol 2007, 102:1739-1744.
11. Hoffman S., Propp J.M., McCarthy B.J. Temporal trends in incidence of primary brain tumors in the United States, 1985-1999. Neuro Oncol 2006, 8:27-37.
12. Han Y.Y., Dinse G.E., Umbach D.M., et al. Age-period-cohort analysis of cancers not related to tobacco, screening, or HIV: sex and race differences. Cancer Causes Control 2010, 21:1227-1236.
13. Lyman G.H., Dale D.C., Wolff D.A., et al. Acute myeloid leukemia or myelodysplastic syndrome in randomized controlled clinical trials of cancer chemotherapy with granulocyte colony-stimulating factor: a systematic review. J Clin Oncol 2010, 28:2914-2924.
14. Gruschkus S.K., Lairson D., Dunn J.K., et al. Use of white blood cell growth factors and risk of acute myeloid leukemia or myelodysplastic syndrome among elderly patients with non-Hodgkin lymphoma. Cancer 2010, 116:5279-5289.
15. Willeit P., Willeit J., Mayr A., et al. Telomere length and risk of incident cancer and cancer mortality. JAMA 2010, 304:69-75.
16. Houben J.M., Giltay E.J., Rius-Ottenheim N., et al. Telomere length and mortality in elderly men: the Zutphen Elderly Study. J Gerontol A Biol Sci Med Sci 2010, 66:38-44.
17. Shultz T.F. Cancer and Viral infections in the immunocompromised host. Int J Cancer 2009, 125:1755-1763.
18. Rodier F., Campisi J. Four faces of cellular senescence. J Cell Biol 2011, 192:547-556.
19. Anisimov V.N., Berstein L.M., Popovich I.G., et al. If started early in life, metformin treatment increases life span and postpones tumors in female SHR mice. Aging (Albany NY) 2011, 3:148-157.
20. Pais R., Silaghi H., Silaghi A.C. Metabolic syndrome and risk of colorectal cancer. World J Gastroenterol 2009, 15:5141-5148.
21. Carreca I., Balducci L. Cancer chemotherapy in the older cancer patient. Urol Oncol 2009, 27:633-642.
22. Roellig C., Thiede C., Gramatzky M., et al. A novel prognostic model in elderly patients with acute myeloid leukemia. Results of 909 patients entered into the prospective AML 96 trial. Blood 2010, 116:971-978.
23. Troch M., Wöhrer S., Raderer M. Assessment of the prognostic indices IPI and FLIPI in patients with mucosa-associated lymphoid tissue lymphoma. Anticancer Res 2010, 30:635-639.
24. Duletić-Nacinović A., Sever-Prebelić M., Stifter S. Interleukin-6 in patients with aggressive and indolent non-Hodgkin's lymphoma: a predictor of prognosis?. Clin Oncol (R Coll Radiol) 2006, 18:367-368.
25. Lee K.W., Kim D.Y., Yun T., et al. Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients: comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage. Cancer 2003, 98:2651-2656.
26. Carlson R.W., Moench S., Hurria A., et al. NCCN task force report: Breast cancer in the older woman. J Natl Compr Canc Netw 2008, 6(Suppl 4):S1-S25.
27. Veronesi U., Ruini L., Del Vecchio M., et al. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med 1993, 318:1587-1591.
28. Bechis S.K., Carroll P.R., Cooperberg M.R. Impact of age at diagnosis on prostate cancer treatment and survival. J Clin Oncol 2011, 29:235-241.
29. Goodwin J.S., Osborne C. Factors affecting the diagnosis and treatment of older patients with cancer. Comprehensive geriatric oncology 2004, 56-66. Taylor and Francis, London. L. Balducci, G.H. Lyman, W.B. Ershler (Eds.).
30. Terret C., Castel-Kremer E., Albrand G., et al. Effects of comorbidity on screening and early diagnosis of cancer in elderly people. Lancet Oncol 2009, 10:80-87.
31. Luciani A., Balducci L. Multiple primary malignancies. Semin Oncol 2004, 31:264-273.
32. Extermann M., Overcash J., Lyman G.H., et al. Comorbidity and functional status are independent in older cancer patients. J Clin Oncol 1998, 16:1582-1587.
33. Repetto L., Fratino L., Audisio R.A., et al. Comprehensive geriatric assessment adds information to the Eastern Cooperative group Performance Status in Elderly cancer patients. An Italian Group for Geriatric Oncology Study. J Clin Oncol 2002, 20:494-502.
34. Ingram S.S., Seo P.H., Martell R.E., et al. Comprehensive assessment of the elderly cancer patient: the feasibility of self-report methodology. J Clin Oncol 2002, 20:770-775.
35. Ferrell B.A. Care of cancer patients in nursing homes. Oncology (Williston Park) 1992, 6(2 Suppl):141-145.
36. Dunn B.K., Greenwald P. Cancer prevention II: introduction. Semin Oncol 2010, 37:321-326.
37. Goss P.E., Ingle J.N., Alés-Martínez J.E., et al. exemestane and breast cancer prevention in postmenopausal women. N Engl J Med 2011, 364:2381-2391.
38. Walsh P.C. Chemoprevention of prostate cancer. N Engl J Med 2010, 362:1237-1238.
39. Rothwell P.M., Wilson M., Elwin C.E., et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 2010, 376:1741-1750.
40. Dunn B.K., Greenwald P. Cancer prevention I: introduction. Semin Oncol 2010, 37:190-201.
41. Reduced lung cancer mortality with low dose computed tomography screening. N Engl J Med 2011, 365:395-409. National Lung Screening Trial Research Team.
42. McCarthy E.P., Burns R.B., Freund K.M., et al. Mammography use, breast cancer stage at diagnosis, and survival among older women. J Am Geriatr Soc 2000, 48:1226-1233.
43. Randolph W.M., Goodwin J.S., Mahnken J.D., et al. Regular mammography use is associated with elimination of age-related disparities in size and stage of breast cancer at diagnosis. Ann Intern Med 2002, 137:783-790.
44. McPherson C.P., Swenson K.K., Lee M.W. The effects of mammographic detection and comorbidity on the survival of older women with breast cancer. J Am Geriatr Soc 2002, 50:1061-1068.
45. Andriole G.L., Grubb R.L., Buys S.S., et al. Mortality results from a randomized prostate cancer screening trial. N Engl J Med 2009, 360:1310-1319.
46. Schroeder F.S., Hugosson J., Roobol M.J., et al. Screening and prostate cancer mortality in a randomized European trial. N Engl J Med 2009, 360:1320-1328.
47. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008, 149:185-191. U.S. Preventive Services Task Force.
48. Bill-Axelson A., Holmberg L., Ruutu M., et al. Radical prostatectomy vs watchful waiting in early prostate cancer. N Engl J Med 2011, 364:1708-1717.
49. Buys S.S., Partridge E., Black A., et al. Effects of screening on ovarian cancer mortality: the Prostate, Lung, Colon and Ovarian (PLCO) cancer screening randomized controlled trial. JAMA 2011, 305:2295-2303.
50. Katlic M.R. Principles of geriatric surgery. Principles and practice of geriatric surgery 2011, 235-252. Springer, New York. 2nd edition. R.A. Rosenthal, M.E. Zenilman, M.R. Katlic (Eds.).
51. Shikanov S., Desai V., Razmaria A., et al. Robotic radical prostatectomy for elderly patients: probability of achieving continence and potency 1 year after surgery. J Urol 2010, 183:1803-1807.
52. Campos J.H. An update on thoracic Robotic Surgery and anesthesia. Curr Opin Anesthesiol 2010, 23:1-6.
53. Lupinacci R., Penna C., Nordlinger B. Hepatectomy for resectable colorectal cancer metastases: indicators of prognosis, definition of respectability, techniques and outcome. Surg Clin North Am 2007, 16:493-506.
54. Stieber V.W., Ellis T.L. The impact of radiosurgery in the management of malignant brain tumors. Curr Treat Options Oncol 2005, 6:501-508.
55. Zimmerman R., Paulus R., Galvin J., et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010, 303:1070-1076.
56. Lo S.S., Moffatt-Bruce S.D., Dawson L.A., et al. The role of local therapy in the management of lung and liver oligometastases. Nat Rev Clin Oncol 2011, 8:405-416.
57. Minn A.Y., Koong A.C., Chang D.T. Stereotactic body radiation therapy for gastrointestinal malignancies. Front Radiat Ther Oncol 2011, 43:412-427.
58. Gaspar L.E., Ding M. A review of intensity modulated radiation therapy. Curr Oncol Rep 2008, 10:2094-2099.
59. Nour S.G. MR guided and monitored radiofrequency tumor ablation. Acad Radiol 2005, 12:1110-1120.
60. Roscoe P.A., Kucharczuc J.C., Kaiser L.R. Esophageal cancer in the elderly. Principles and practice of geriatric surgery 2011, 747-762. Springer, New York. 2nd edition. R.A. Rosenthal, M.E. Zenilman, M.R. Katlic (Eds.).
61. Oliver A.L., Ashley S.W., Breen E., et al. Neoplastic diseases of the colon and rectum. Principles and practice of geriatric surgery 2011, 889-906. Springer, New York. 2nd edition. R.A. Rosenthal, M.E. Zenilman, M.R. Katlic (Eds.).
62. Mulcahy M.F., Lewandowski R.J., Ibrahim S.M., et al. Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres. Cancer 2009, 115:1849-1858.
63. Arciero C.A., Sigurdson E.R. Diagnosis and treatment of metastatic disease to the liver. Semin Oncol 2008, 35:147-159.
64. Balducci L. Treating elderly patients with hormone-sensitive breast cancer: what do the data show?. Cancer Treat Rev 2009, 35:47-56.
65. Robertson J.F. Fulvestrant: how to make a good drug better. Oncologist 2007, 12:774-784.
66. Flüchter S.H., Weiser R., Gamper C. The role of hormonal treatment in prostate cancer. Recent Results Cancer Res 2007, 175:211-237.
67. Shore N.D., Crawford E.D. Intermittent androgen deprivation therapy: redefining the standard of care?. Rev Urol 2010, 12:1-11.
68. de Bono J.S., Logothetis C.J., Molina A., et al. Abiraterone and increased survival in metastatic prostate cancer. N Engl J Med 2011, 364:1995-2005.
69. Balducci L. Pharmacology of antineoplastic medications in older cancer patients. Oncology 2009, 23:78-85.
70. Shayne M., Balducci L. Hematopoietic growth factors in older cancer patients. Cancer Treat Res 2011, 157:383-402.
71. Balducci L. Non hematologic complications of systemic treatment of cancer in the older-aged person. Management of cancer in the older patient 2011, 127-133. Elsevier Saunders, Philadelphia. A. Naeim, D.B. Reuben, P.A. Ganz (Eds.).
72. Kelly C.M., Krishnamurthy S., Bianchini G., et al. Utility of oncotype DX risk estimates in clinically intermediate risk hormone receptor-positive, HER2-normal, grade II, lymph node-negative breast cancers. Cancer 2010, 116:5161-5167.
73. Lin H., Balic M., Zheng S., et al. Disseminated and circulating tumor cells: role in effective cancer management. Crit Rev Oncol Hematol 2011, 77:1-11.
74. Kantoff P.W., Higano C.S., Shore N.D., et al. Sipoleucel T immunotherapy in castrate-resistant prostate cancer. N Engl J Med 2010, 363:411-422.
75. Gonsalves W., Ganti A.K. Targeted anticancer therapy in the elderly. Crit Rev Oncol Hematol 2011, 78:227-242.
76. Balducci L. Molecular insights in cancer treatment and prevention. Int J Biochem Cell Biol 2007, 39:1329-1337.
77. Serrano C., Cortés J., De Mattos-Arruda L., et al. Trastuzumab-related cardiotoxicity in the elderly: role of cardiovascular risk factors. Ann Oncol 2011 Aug 9, [Epub ahead of print].
78. Medina P.J., Goodin S. Lapatinib: a dual inhibitor of epidermal growth factor receptor tyrosine kinases. Clin Ther 2008, 30:1426-1447.
79. Lee S.J., Lindquist K., Segal M.R., et al. Development and validation of a prognostic index for 4-year mortality in older adults. JAMA 2006, 295:801-808.
80. Carey E.C., Covinsky K.E., Lui L.Y., et al. Prediction of mortality in community-living frail elderly people with long-term care needs. J Am Geriatr Soc 2008, 56:68-75.
81. Pope R., Ramesh H., Gennari R., et al. Pre-operative assessment of cancer in the elderly: a comprehensive assessment of underlying characteristics of elderly cancer patients. Surg Oncol 2006, 15:189-197.
82. Hurria A., Togawa K., Mohile S.G., et al. Predicting chemotherapy toxicity in older adults with cancer. J Clin Oncol 2011, 29:3457-3465.